Palvella Therapeutics (PVLA) Prepaid Assets (2013 - 2026)
Palvella Therapeutics (PVLA) reported Prepaid Assets of $1.4 million for Q1 2026, down 24.9% year-over-year from $1.8 million in Q1 2025, and up 37.11% quarter-over-quarter from $1.0 million in Q4 2025.
Palvella Therapeutics (PVLA) Prepaid Assets (2013 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has 14 years of Prepaid Assets data on file, last reported at $1.4 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $1.4 million, down 24.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 24.9% YoY), and the FY2025 annual result was $1.0 million, down 56.23% from the prior year.
- Prepaid Assets improved to $1.4 million in Q1 2026 per PVLA's latest filing, from $1.0 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $11.1 million in Q1 2023 and troughed at $198000.0 in Q4 2023.
- A 5-year average of $4.3 million and a median of $2.3 million in 2024 frame the typical range for Prepaid Assets.
- On a YoY basis, Prepaid Assets climbed as much as 1059.6% in 2024 and fell as far as 96.94% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $3.2 million in 2022, then sank by 93.84% to $198000.0 in 2023, then jumped by 1059.6% to $2.3 million in 2024, then tumbled by 56.23% to $1.0 million in 2025, then surged by 37.11% to $1.4 million in 2026.
- Business Quant data shows PVLA's Prepaid Assets at $1.4 million in Q1 2026, $1.0 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Palvella Therapeutics | 1.49 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 280,000.00 |
| Jun 30, 2024 | 649,000.00 |
| Mar 31, 2024 | 2.97 Mn |
| Dec 31, 2023 | 198,000.00 |
| Sep 30, 2023 | 9.15 Mn |
| Jun 30, 2023 | 10.65 Mn |
| Mar 31, 2023 | 11.07 Mn |
| Dec 31, 2022 | 3.21 Mn |
| Sep 30, 2022 | 7.91 Mn |
| Jun 30, 2022 | 8.70 Mn |
| Mar 31, 2022 | 9.84 Mn |
| Dec 31, 2021 | 6.55 Mn |
| Sep 30, 2021 | 5.95 Mn |
| Jun 30, 2021 | 5.77 Mn |